Preclinical Services for HIV Therapeutics

The National Institutes of Health has awarded a competitive multiple-award, Indefinite Delivery/Indefinite Quantity (IDIQ) contract to support preclinical services for HIV therapeutics. This award, categorized under NAICS code 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AJ12 for General Science and Technology R&D Services; General Science and Technology; Applied Research, facilitates work specifically within Task Area E. The contract features a seven-year ordering period running from October 15, 2020, through October 14, 2027, with primary performance located in Iowa City, IA.

While fixed-price task orders may be issued where feasible, the government anticipates that most task orders under this vehicle will be cost-reimbursement, term/completion types. This determination is based on the dynamic, science-responsive nature of the requirements and the difficulty in establishing precise specifications for estimating costs with accuracy. This structure provides the flexibility necessary to address evolving needs and mitigates government risk in a result-driven research environment. This award concludes the solicitation process for notice 75N93019R00021.